United StatesBreaking News

Korn Ferry (NYSE:KFY) has entered into a definitive agreement to acquire UK-headquartered AMS, creating a global leader in talent and organizational consulting.

Zymeworks has agreed to acquire Theravance Biopharma (NASDAQ:TBPH) for $17 per share in cash.

Israel, Lebanon, and the US reached an initial trilateral framework agreement aimed at paving the way for ending the conflict between Israel and Lebanon and ultimately reaching a peace settlement. Bloomberg's Dan Williams reports.

Kandi Technologies (NASDAQ:KNDI) has agreed to acquire a 51% controlling stake in Hangzhou Xinchu New Energy for RMB20 million, approximately US$2.9 million, in cash.

South Korea is orchestrating investments of at least 1,350 trillion won ($880 billion) from companies including Samsung and SK Hynix into chips and data centers, a giant outlay in digital infrastructure it called essential to surviving the AI era. Bloomberg's Shona Ghosh has more.

Kongsberg has seen a "positive movement forward" in European defense spending throughout last year, even though it's still not yet at the level needed, its CEO Eirik Lie tells Bloomberg TV. Lie spoke to Bloomberg TV's Francine Lacqua ahead of July's NATO summit in Ankara, Turkey, where European NATO states will be expected to prove they are progressing towards spending 5% of GDP on defense.

South Korea is launching a 1,350 trillion won ($880 billion) plan in corporate investments to build out critical AI infrastructure and cement its global dominance in the semiconductor market. President Lee Jae Myung called the sweeping mega-project a "national survival strategy" for the AI era. Bloomberg's Avril Hong breaks down the press conference, where President Lee was joined by the CEOs of tech giants Samsung and SK Hynix to outline the multi-year roadmap.

Daiichi Sankyo and AstraZeneca (NASDAQ:AZN) announced that Enhertu (trastuzumab deruxtecan) has been approved in the European Union as monotherapy for the treatment of adult patients with unresectable or metastatic HER2 positive (IHC 3+) solid tumors who have received prior treatment and who have no satisfactory alternative treatment options.

AbbVie (NYSE:ABBV) said the CHMP has issued a positive opinion recommending approval of upadacitinib (RINVOQ) 15 mg and 30 mg once daily for adults and adolescents with severe alopecia areata in the EU.

Anna Edwards, Guy Johnson, Tom Mackenzie and Mark Cudmore break down today's key themes for analysts and investors on "Bloomberg: The Opening Trade."

Waymo, owned by Alphabet (NASDAQ:GOOGL), has ended its Phoenix robotaxi availability on Uber Technologies (NYSE:UBER), closing a pilot that delivered hundreds of thousands of autonomous trips.

BCAL Diagnostics (ASX:BDX), an Australian healthcare company focused on early cancer detection, has secured firm commitments for a further A$4.9 million under its existing A$10 million convertible note facility, with the additional funds to be drawn down as required.